首页> 外国专利> APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION

APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION

机译:中药组合物在治疗或预防冠状病毒感染的制备中的应用

摘要

An application of a traditional Chinese medicine composition in preparation of drugs for treating or preventing coronavirus infection. The traditional Chinese medicine composition is prepared from the following active pharmaceutical ingredients in parts by weight: 5-15 parts of Cornu Saigae Tataricae or 50-150 parts of goat horns, 10-60 parts of Bulbus Fritillariae Ussuriensis, 15-60 parts of Radix et Rhizoma Rhei, 7-30 parts of Baical Skullcap Root, 7-30 parts of Lapis Chloriti, 10-50 parts of Gypsum Fibrosum, 5-20 parts of Calculus Bovis Artifactus, and 15-60 parts of Radix Glycyrrhizae. The traditional Chinese medicine composition can inhibit intracellular replication of 2019-nCoV, will not pathologically alter infected cells, and can treat or prevent related diseases caused by coronavirus infection.
机译:中药组合物在制备药物治疗或预防冠状病毒感染中的应用。 中药组合物由下列活性药物成分中的重量份:5-15份玉米赛羚羊塔塔利卡(Cornu Saigae Tataricae)或50-150份山羊角,10-60份Bulbus Fritillariae Ussuriensis,15-60份的基数 ETRrizoma Rhei,7-30份Baical Skullcap Root,7-30份Lapis Chloriti,10-50份石膏纤维纤维,5-20份Calculus Bovis Artifactus,以及15-60份Radix Glycyrrhizae。 中药组合物可以抑制2019年 - NCOV的细胞内复制,不会病于病理上改变感染细胞,并且可以治疗或预防由冠状病毒感染引起的相关疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号